January 27, 2026

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Exploring a 45% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a key player in the biotechnology industry, holds a promising position in the healthcare sector with its focus on developing treatments..

Perrigo Company plc (PRGO): Investor Outlook Reveals a Potential 45.83% Upside

Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector, is making waves with a potential upside of 45.83% as suggested by its average..

Zai Lab Limited (ZLAB) Stock Analysis: Eyeing a 169% Potential Upside in the Biotech Arena

Zai Lab Limited (NASDAQ: ZLAB) has emerged as a significant player in the biotech sector, with a focus on pioneering therapies in oncology, immunology, neuroscience, and..

Merus N.V. (MRUS) Stock Analysis: Exploring the Potential 7.78% Upside in the Biotech Sector

Merus N.V. (MRUS), a prominent player in the biotechnology sector, operates from the Netherlands with a keen focus on developing innovative antibody therapeutics. Although Merus is..

Privia Health Group, Inc. (PRVA) Stock Analysis: A Healthcare Innovator with 29.67% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA) is generating buzz in the healthcare sector as a promising player in the health information services industry. Based in Arlington,..

Concentra Group Holdings Parent (CON) Stock Analysis: A Healthcare Play with a 28% Upside Potential

Investors with a keen eye on the healthcare sector may find Concentra Group Holdings Parent (NASDAQ: CON) an intriguing opportunity. With its robust presence in the..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A 31% Potential Upside in Neurological Innovations

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a pioneering force in the biotechnology sector, is drawing considerable attention from investors due to its focused efforts on developing treatments..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unpacking the 52.71% Potential Upside for Investors

CRISPR Therapeutics AG (NASDAQ: CRSP), a leader in the biotechnology sector, is making headlines with its promising gene-editing technologies. With an impressive market cap of $5.21..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 34.56% Upside Potential in the Medical Devices Sector

Haemonetics Corporation (NYSE: HAE), a Boston-based innovator in medical technology, is capturing the attention of investors with its robust portfolio of healthcare solutions. The company’s strategic..

Metsera, Inc. (MTSR) Stock Analysis: Navigating the Uncharted Waters of a Clinical-Stage Biotech

Investors intrigued by the high-risk, high-reward nature of biotechnology stocks may find Metsera, Inc. (MTSR) an interesting case study. As a clinical-stage biotech company operating under..

QuidelOrtho Corporation (QDEL) Investor Outlook: Analyzing a Potential 33.66% Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL) is a prominent player in the healthcare sector, specializing in medical devices, particularly diagnostic testing solutions. With a market capitalization of $1.95..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Exploring a 56.89% Upside Potential

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands out in the biotechnology sector with a market capitalization of $2.78 billion. As a player in the healthcare industry, Apellis..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Unveiling a Potential 60.89% Upside with Innovative Endocrine Solutions

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), headquartered in San Diego, California, stands as a beacon in the biotechnology sector, focusing on novel therapeutics for rare endocrine diseases..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 51.55% Upside Potential in the Biotech Sector

Immunovant, Inc. (IMVT), a prominent player in the biotechnology sector, has captured the attention of investors with its clinical-stage developments targeting autoimmune diseases. The New York-based..

Time Finance adds strategic hire to support £300m lending target

Strategic hire strengthens Time Finance’s intermediary reach as part of long-term lending growth plan...

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Biotechnology Innovator with 12% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) stands out in the biotechnology sector with its innovative approach to treating serious diseases through targeted protein growth factor therapies...

PROCEPT BioRobotics (PRCT): A Robotics Innovator with a 71% Potential Upside

For investors with a keen eye on the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents an intriguing prospect. Specializing in medical devices, this San Jose-based..

Viking Therapeutics (VKTX): Analyst Ratings Indicate a Potential Upside of Over 194%

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, is garnering significant attention from investors with its promising drug pipeline and substantial potential upside. With a..

Arcellx, Inc. (ACLX) Stock Analysis: Unpacking a 63.90% Potential Upside in the Biotech Sector

Arcellx, Inc. (NASDAQ: ACLX), a promising player in the biotechnology sector, has caught the attention of investors with its robust pipeline of immunotherapies targeting cancer and..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Potential Upside with Innovative Rare Disorder Treatments

PTC Therapeutics, Inc. (PTCT) stands out in the biotechnology sector with its focus on developing and commercializing treatments for rare disorders. Headquartered in Warren, New Jersey,..

Search

Funds

January 27, 2026

Time Finance adds strategic hire to support £300m lending target

Strategic hire strengthens Time Finance’s intermediary reach as part of long-term lending growth plan...
Search

Funds

January 27, 2026

FTSE 100

Funds